[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @PDUFA_Pulse PDUFA Pulse PDUFA Pulse posts on X about $kura, $beam, $amgn, the daily the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1688765842757238784/interactions)  - X Week XXXXX +11% - X Month XXXXXX -XX% - X Months XXXXXX +793% - X Year XXXXXX +70% ### Mentions: X [#](/creator/twitter::1688765842757238784/posts_active)  - X Week XX -XX% - X Month XX +2% - X Months XX +822% - X Year XX +557% ### Followers: XXX [#](/creator/twitter::1688765842757238784/followers)  - X Week XXX +5.70% - X Month XXX +29% - X Months XXX +153% - X Year XXX +172% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1688765842757238784/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [cryptocurrencies](/list/cryptocurrencies) **Social topic influence** [$kura](/topic/$kura), [$beam](/topic/$beam), [$amgn](/topic/$amgn), [the daily](/topic/the-daily), [biontech](/topic/biontech), [$dna](/topic/$dna), [$47m](/topic/$47m), [ai](/topic/ai), [$jnj](/topic/$jnj) **Top assets mentioned** [BEAM (BEAM)](/topic/$beam) [Amgen, Inc. (AMGN)](/topic/$amgn) [Muhdo Hub (DNA)](/topic/$dna) [Johnson & Johnson (JNJ)](/topic/$jnj) ### Top Social Posts Top posts by engagements in the last XX hours "🧬 Forget the Santa Rally its ASH Season. The American Society of Hematology (ASH) meeting kicks off this weekend (Dec 6-9) and the abstracts are already moving markets. While we watch the PDUFA calendar keep an eye on data readouts from $KURA (Kura Oncology) and $BEAM (Beam Therapeutics). The focus this year is heavily on Menin inhibitors and next-gen gene editing for Sickle Cell" [X Link](https://x.com/PDUFA_Pulse/status/1995930974325215702) 2025-12-02T19:00Z XXX followers, XXX engagements "📈 THE 6-MONTH REVOLUTION: Amgen & GSK aim to kill the daily pill.The second half of December isn't just about approval; it's about Lifestyle Leverage. 🧠 Dec 14: $AMGN (Amgen) Uplizna (gMG) The Edge: While competitors like Vyvgart require frequent infusions Uplizna brings a twice-yearly dosing schedule to Myasthenia Gravis. In a crowded neurology market convenience is the ultimate moat. 🫁 Dec 16: $GSK Depemokimab (Asthma & CRSwNP) The Edge: The First Ultra-Long-Acting Biologic.We are talking about switching from daily inhalers/pills to just two shots a year. Indication 1: Severe Asthma" [X Link](https://x.com/PDUFA_Pulse/status/1996282787339669565) 2025-12-03T18:18Z XXX followers, XXX engagements "Big news from #SABCS25: BioNTech + Bristol Myers Squibb just dropped promising Phase X data for pumitamig a PD-L1 VEGF-A bispecific in pretreated triple-negative breast cancer.Key highlights: Encouraging ORR and PFS in a tough-to-treat population Potential first-in-class combo hitting both immune checkpoint and angiogenesis Another step forward for patients with TNBC who desperately need new options. #Oncology #Immunotherapy #BreastCancer Full data presented today in San Antonio" [X Link](https://x.com/PDUFA_Pulse/status/1998386826059620782) 2025-12-09T13:38Z XXX followers, XXX engagements "Ginkgo Bioworks $DNA just secured a $47M contract from the U.S. Department of Energy to build the countrys first fully autonomous AI-powered microbial labs This is part of the Genesis Mission push to accelerate biofuels sustainable materials and next-gen therapeutics using robotics + AI. From years months for strain engineering Possibly a game-changing infrastructure move" [X Link](https://x.com/PDUFA_Pulse/status/1998515540390977880) 2025-12-09T22:10Z XXX followers, XXX engagements "Just in from ASH 2025: J&Js Tecvayli + Darzalex combo is showing a flattened OS curve in relapsed multiple myeloma. A potential functional cure signal in XX% of patients after X years. Biggest myeloma advance in decades. $JNJ" [X Link](https://x.com/PDUFA_Pulse/status/1998734757811859896) 2025-12-10T12:41Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PDUFA_Pulse PDUFA PulsePDUFA Pulse posts on X about $kura, $beam, $amgn, the daily the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks cryptocurrencies
Social topic influence $kura, $beam, $amgn, the daily, biontech, $dna, $47m, ai, $jnj
Top assets mentioned BEAM (BEAM) Amgen, Inc. (AMGN) Muhdo Hub (DNA) Johnson & Johnson (JNJ)
Top posts by engagements in the last XX hours
"🧬 Forget the Santa Rally its ASH Season. The American Society of Hematology (ASH) meeting kicks off this weekend (Dec 6-9) and the abstracts are already moving markets. While we watch the PDUFA calendar keep an eye on data readouts from $KURA (Kura Oncology) and $BEAM (Beam Therapeutics). The focus this year is heavily on Menin inhibitors and next-gen gene editing for Sickle Cell"
X Link 2025-12-02T19:00Z XXX followers, XXX engagements
"📈 THE 6-MONTH REVOLUTION: Amgen & GSK aim to kill the daily pill.The second half of December isn't just about approval; it's about Lifestyle Leverage. 🧠 Dec 14: $AMGN (Amgen) Uplizna (gMG) The Edge: While competitors like Vyvgart require frequent infusions Uplizna brings a twice-yearly dosing schedule to Myasthenia Gravis. In a crowded neurology market convenience is the ultimate moat. 🫁 Dec 16: $GSK Depemokimab (Asthma & CRSwNP) The Edge: The First Ultra-Long-Acting Biologic.We are talking about switching from daily inhalers/pills to just two shots a year. Indication 1: Severe Asthma"
X Link 2025-12-03T18:18Z XXX followers, XXX engagements
"Big news from #SABCS25: BioNTech + Bristol Myers Squibb just dropped promising Phase X data for pumitamig a PD-L1 VEGF-A bispecific in pretreated triple-negative breast cancer.Key highlights: Encouraging ORR and PFS in a tough-to-treat population Potential first-in-class combo hitting both immune checkpoint and angiogenesis Another step forward for patients with TNBC who desperately need new options. #Oncology #Immunotherapy #BreastCancer Full data presented today in San Antonio"
X Link 2025-12-09T13:38Z XXX followers, XXX engagements
"Ginkgo Bioworks $DNA just secured a $47M contract from the U.S. Department of Energy to build the countrys first fully autonomous AI-powered microbial labs This is part of the Genesis Mission push to accelerate biofuels sustainable materials and next-gen therapeutics using robotics + AI. From years months for strain engineering Possibly a game-changing infrastructure move"
X Link 2025-12-09T22:10Z XXX followers, XXX engagements
"Just in from ASH 2025: J&Js Tecvayli + Darzalex combo is showing a flattened OS curve in relapsed multiple myeloma. A potential functional cure signal in XX% of patients after X years. Biggest myeloma advance in decades. $JNJ"
X Link 2025-12-10T12:41Z XXX followers, XX engagements
/creator/twitter::PDUFA_Pulse